$BCTX reveals promising preclinical data for their Bria-BRES+™ for breast cancer and Bria-PROS+™ for prostate cancer, at #SITC2024. Early results show strong anti-cancer activity and immune activation—exciting progress for cancer care! Learn more: https://www.globenewswire.com/en/news-release...rence.html